Literature DB >> 8931709

Germline mutations in the 3' part of APC exon 15 do not result in truncated proteins and are associated with attenuated adenomatous polyposis coli.

R B van der Luijt1, P Meera Khan, H F Vasen, C Breukel, C M Tops, R J Scott, R Fodde.   

Abstract

Familial adenomatous polyposis (FAP) is an inherited predisposition to colorectal cancer characterized by the development of numerous adenomatous polyps predominantly in the colorectal region. Germline mutations in the adenomatous polyposis coli (APC) gene are responsible for most cases of FAP. Mutations at the 5' end of APC are known to be associated with a relatively mild form of the disease, called attenuated adenomatous polyposis coli (AAPC). We identified a frameshift mutation in the 3' part of exon 15, resulting in a stop codon at 1862, in a large Dutch kindred with AAPC. Western blot analysis of lymphoblastoid cell lines derived from affected family members from this kindred, as well as from a previously reported Swiss family carrying a frameshift mutation at codon 1987 and displaying a similar attenuated phenotype, showed only the wild-type APC protein. Our study indicates that chain-terminating mutations located in the 3' part of APC do not result in detectable truncated polypeptides and we hypothesize that this is likely to be the basis for the observed AAPC phenotype.

Entities:  

Mesh:

Year:  1996        PMID: 8931709     DOI: 10.1007/s004390050293

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  40 in total

1.  Genotype-phenotype correlations in attenuated adenomatous polyposis coli.

Authors:  C Soravia; T Berk; L Madlensky; A Mitri; H Cheng; S Gallinger; Z Cohen; B Bapat
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

2.  Colorectal cancer in two pre-teenage siblings with familial adenomatous polyposis.

Authors:  Silvija Jerkic; Hendrik Rosewich; Jens-Gerd Scharf; Christina Perske; Laszlo Füzesi; Ekkehard Wilichowski; Jutta Gärtner
Journal:  Eur J Pediatr       Date:  2005-02-22       Impact factor: 3.183

3.  Apc(MIN) modulation of vitamin D secosteroid growth control.

Authors:  Haibo Xu; Gary H Posner; Michael Stevenson; Frederick C Campbell
Journal:  Carcinogenesis       Date:  2010-05-20       Impact factor: 4.944

4.  Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families.

Authors:  W Friedl; R Caspari; M Sengteller; S Uhlhaas; C Lamberti; M Jungck; M Kadmon; M Wolf; J Fahnenstich; J Gebert; G Möslein; E Mangold; P Propping
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

Review 5.  Genomic era diagnosis and management of hereditary and sporadic colon cancer.

Authors:  Edward David Esplin; Michael Paul Snyder
Journal:  World J Clin Oncol       Date:  2014-12-10

6.  The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family history.

Authors:  I M Frayling; N E Beck; M Ilyas; I Dove-Edwin; P Goodman; K Pack; J A Bell; C B Williams; S V Hodgson; H J Thomas; I C Talbot; W F Bodmer; I P Tomlinson
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

7.  Variable phenotype of familial adenomatous polyposis in pedigrees with 3' mutation in the APC gene.

Authors:  J D Brensinger; S J Laken; M C Luce; S M Powell; G H Vance; D J Ahnen; G M Petersen; S R Hamilton; F M Giardiello
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

8.  Inherited colorectal polyposis and cancer risk of the APC I1307K polymorphism.

Authors:  R Gryfe; N Di Nicola; G Lal; S Gallinger; M Redston
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

9.  Familial adenomatous polyposis: experience from a study of 1164 unrelated german polyposis patients.

Authors:  Waltraut Friedl; Stefan Aretz
Journal:  Hered Cancer Clin Pract       Date:  2005-09-15       Impact factor: 2.857

10.  Broad phenotypic spectrum in familial adenomatous polyposis; from early onset and severe phenotypes to late onset of attenuated polyposis with the first manifestation at age 72.

Authors:  Mef Nilbert; Ulf Kristoffersson; Mats Ericsson; Oskar Johannsson; Eva Rambech; Peter Mangell
Journal:  BMC Med Genet       Date:  2008-11-26       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.